Step-in dosing of bosutinib in pts with chronic phase chronic myeloid leukemia (CML) after second-generation tyrosine kinase inhibitor (TKI) therapy: results of the Bosutinib Dose Optimization (BODO) Study.
Annals of hematology
View this publicationAnnals of hematology
View this publicationCellular and molecular life sciences : CMLS
View this publicationJournal of clinical medicine
View this publicationAnnals of clinical and translational neurology
View this publicationCell
View this publicationAmerican journal of medical genetics. Part C, Seminars in medical genetics
View this publicationCirculation. Cardiovascular interventions
View this publicationVaccines
View this publicationDigestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
View this publicationAngiology
View this publication